205 related articles for article (PubMed ID: 2778657)
1. Predicting the solubility of sulfamethoxypyridazine in individual solvents. I: Calculating partial solubility parameters.
Bustamante P; Escalera B; Martin A; Sellés E
J Pharm Sci; 1989 Jul; 78(7):567-73. PubMed ID: 2778657
[TBL] [Abstract][Full Text] [Related]
2. Predicting the solubility of sulfamethoxypyridazine in individual solvents. II: Relationship between solute-solvent interaction terms and partial solubility parameters.
Martin A; Bustamante P; Escalera B; Sellés E
J Pharm Sci; 1989 Aug; 78(8):672-8. PubMed ID: 2778673
[TBL] [Abstract][Full Text] [Related]
3. Solubility behaviour of haloperidol in individual solvents determination of partial solubility parameters.
Subrahmanyam CV; Suresh S
Eur J Pharm Biopharm; 1999 May; 47(3):289-94. PubMed ID: 10382114
[TBL] [Abstract][Full Text] [Related]
4. Partial solubility parameters and solvatochromic parameters for predicting the solubility of single and multiple drugs in individual solvents.
Bustamante P; Martin A; Gonzalez-Guisandez MA
J Pharm Sci; 1993 Jun; 82(6):635-40. PubMed ID: 8331539
[TBL] [Abstract][Full Text] [Related]
5. Extended Hansen solubility approach: naphthalene in individual solvents.
Martin A; Wu PL; Adjei A; Beerbower A; Prausnitz JM
J Pharm Sci; 1981 Nov; 70(11):1260-4. PubMed ID: 7299673
[TBL] [Abstract][Full Text] [Related]
6. Expanded solubility parameter approach. I: Naphthalene and benzoic acid in individual solvents.
Beerbower A; Wu PL; Martin A
J Pharm Sci; 1984 Feb; 73(2):179-88. PubMed ID: 6707879
[TBL] [Abstract][Full Text] [Related]
7. Extended Hansen's solubility approach: meloxicam in individual solvents.
Babu PR; Subrahmanyam CV; Thimmasetty J; Manavalan R; Valliappan K
Pak J Pharm Sci; 2007 Oct; 20(4):311-6. PubMed ID: 17604255
[TBL] [Abstract][Full Text] [Related]
8. Extended Hansen approach: calculating partial solubility parameters of solid solutes.
Wu PL; Beerbower A; Martin A
J Pharm Sci; 1982 Nov; 71(11):1285-7. PubMed ID: 7175725
[TBL] [Abstract][Full Text] [Related]
9. Expanded solubility parameter approach. II: p-Hydroxybenzoic acid and methyl p-hydroxybenzoate in individual solvents.
Martin A; Wu PL; Beerbower A
J Pharm Sci; 1984 Feb; 73(2):188-94. PubMed ID: 6707880
[TBL] [Abstract][Full Text] [Related]
10. Relationship between swelling of hydroxypropylmethylcellulose and the Hansen and Karger partial solubility parameters.
Navarro-Lupión FJ; Bustamante P; Escalera B
J Pharm Sci; 2005 Jul; 94(7):1608-16. PubMed ID: 15920774
[TBL] [Abstract][Full Text] [Related]
11. The expanded Hansen approach to solubility parameters. Paracetamol and citric acid in individual solvents.
Barra J; Lescure F; Doelker E; Bustamante P
J Pharm Pharmacol; 1997 Jul; 49(7):644-51. PubMed ID: 9255705
[TBL] [Abstract][Full Text] [Related]
12. Predicting the solubility of drugs in solvent mixtures: multiple solubility maxima and the chameleonic effect.
Escalera JB; Bustamante P; Martin A
J Pharm Pharmacol; 1994 Mar; 46(3):172-6. PubMed ID: 8027922
[TBL] [Abstract][Full Text] [Related]
13. Extended Hildebrand Solubility Approach: methylxanthines in mixed solvents.
Martin A; Paruta AN; Adjei A
J Pharm Sci; 1981 Oct; 70(10):1115-20. PubMed ID: 7299644
[TBL] [Abstract][Full Text] [Related]
14. Solubility of hydrocortisone in organic and aqueous media: evidence for regular solution behavior in apolar solvents.
Hagen TA; Flynn GL
J Pharm Sci; 1983 Apr; 72(4):409-14. PubMed ID: 6864481
[TBL] [Abstract][Full Text] [Related]
15. The modified extended Hansen method to determine partial solubility parameters of drugs containing a single hydrogen bonding group and their sodium derivatives: benzoic acid/Na and ibuprofen/Na.
Bustamante P; Pena MA; Barra J
Int J Pharm; 2000 Jan; 194(1):117-24. PubMed ID: 10601690
[TBL] [Abstract][Full Text] [Related]
16. Partial solubility parameters of lactose, mannitol and saccharose using the modified extended Hansen method and evaporation light scattering detection.
Peña MA; Daali Y; Barra J; Bustamante P
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):179-83. PubMed ID: 10705501
[TBL] [Abstract][Full Text] [Related]
17. The hydrophobic effect. 2. Relative importance of the hydrophobic effect on the solubility of hydrophobes and pharmaceuticals in H-bonded solvents.
Ruelle P; Kesselring UW
J Pharm Sci; 1998 Aug; 87(8):998-1014. PubMed ID: 9687345
[TBL] [Abstract][Full Text] [Related]
18. Thermochemical investigations of associated solutions: calculation of solute--solvent equilibrium constants from solubility measurements.
Acree WE; McHan DR; Rytting JH
J Pharm Sci; 1983 Aug; 72(8):929-34. PubMed ID: 6620150
[TBL] [Abstract][Full Text] [Related]
19. Prediction of solubility in nonideal multicomponent systems using the UNIFAC group contribution model.
Ochsner AB; Sokoloski TD
J Pharm Sci; 1985 Jun; 74(6):634-7. PubMed ID: 4020650
[TBL] [Abstract][Full Text] [Related]
20. Excess free energy approach to the estimation of solubility in mixed solvent systems I: Theory.
Williams NA; Amidon GL
J Pharm Sci; 1984 Jan; 73(1):9-13. PubMed ID: 6694092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
